Paratek Phase IIb data shows omadacycline’s potential to address unmet needs in NTM treatment, says…
The placebo-controlled trial enrolled 66 patients with NTM pulmonary disease caused by MABc. In the study, oral omadacycline was…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.